Cargando…

Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis

INTRODUCTION: Primary sclerosing cholangitis (PSC) is a progressive liver disease characterized by bile duct inflammation and fibrosis. The role of macrophages in PSC development and progression is less studied. Macrophage activation markers soluble (s)CD163 and mannose receptor (sMR) are associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bossen, Lars, Vesterhus, Mette, Hov, Johannes R., Färkkilä, Martti, Rosenberg, William M., Møller, Holger J., Boberg, Kirsten M., Karlsen, Tom H., Grønbæk, Henning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925135/ https://www.ncbi.nlm.nih.gov/pubmed/33646203 http://dx.doi.org/10.14309/ctg.0000000000000315

Ejemplares similares

Autotaxin activity predicts transplant-free survival in primary sclerosing cholangitis
por: Dhillon, Amandeep K., et al.
Publicado: (2019)

Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities
por: Vesterhus, Mette, et al.
Publicado: (2020)

Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis
por: Braadland, Peder Rustøen, et al.
Publicado: (2022)

Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile
por: Vedeld, Hege Marie, et al.
Publicado: (2021)

Refinement of the MHC Risk Map in a Scandinavian Primary Sclerosing Cholangitis Population
por: Næss, Sigrid, et al.
Publicado: (2014)

Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF
por: Fossdal, Guri, et al.
Publicado: (2021)

Electrostatic Modifications of the Human Leukocyte Antigen-DR P9 Peptide-Binding Pocket and Susceptibility to Primary Sclerosing Cholangitis
por: Hov, Johannes R, et al.
Publicado: (2011)

A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation
por: Hole, Mikal Jacob, et al.
Publicado: (2023)

Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway
por: Andersen, Ina M., et al.
Publicado: (2015)

Novel histological scoring for predicting disease outcome in primary sclerosing cholangitis
por: Sjöblom, Nelli, et al.
Publicado: (2022)

Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma
por: Forsbring, Monika, et al.
Publicado: (2009)

Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia
por: Pereira, Pedro, et al.
Publicado: (2017)

Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis
por: Boyd, Sonja, et al.
Publicado: (2017)

Quantitative bile and serum proteomics for the screening and differential diagnosis of primary sclerosing cholangitis
por: Holm, Matilda, et al.
Publicado: (2022)

Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link?
por: O’Hara, Steven P, et al.
Publicado: (2017)

Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis
por: Rühlemann, Malte, et al.
Publicado: (2019)

Mutational Characterization of the Bile Acid Receptor TGR5 in Primary Sclerosing Cholangitis
por: Hov, Johannes R., et al.
Publicado: (2010)

PNPLA3 allele frequency has no impact on biliary bile acid composition or disease course in patients with primary sclerosing cholangitis
por: Färkkilä, Martti, et al.
Publicado: (2022)

Impact on follow‐up strategies in patients with primary sclerosing cholangitis
por: Bergquist, Annika, et al.
Publicado: (2022)

Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022)

Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease
por: Vesterhus, Mette, et al.
Publicado: (2020)

Algebraic topology-based machine learning using MRI predicts outcomes in primary sclerosing cholangitis
por: Singh, Yashbir, et al.
Publicado: (2022)

Intrahepatic macrophage populations in the pathophysiology of primary sclerosing cholangitis
por: Chen, Yung-Yi, et al.
Publicado: (2019)

IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis
por: Tanaka, Atsushi
Publicado: (2019)

Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis – A review of cholangiographic and ultrasound imaging
por: Möller, Kathleen, et al.
Publicado: (2022)

Role of Endoscopy in Primary Sclerosing Cholangitis
por: Bhat, Purnima, et al.
Publicado: (2021)

Primary sclerosing cholangitis.
por: Spence, R. A., et al.
Publicado: (1984)

Primary sclerosing cholangitis
por: Worthington, Joy, et al.
Publicado: (2006)

The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis
por: Bossen, Lars, et al.
Publicado: (2023)

Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System
por: Goode, Elizabeth C., et al.
Publicado: (2019)

Gut mycobiome of primary sclerosing cholangitis patients is characterised by an increase of Trichocladium griseum and Candida species
por: Rühlemann, Malte Christoph, et al.
Publicado: (2020)

The immunobiology of primary sclerosing cholangitis
por: Aron, Jonathan H., et al.
Publicado: (2009)

Pathogenesis of primary sclerosing cholangitis
por: Pollheimer, Marion J., et al.
Publicado: (2011)

Primary sclerosing cholangitis and pregnancy
por: Kammeijer, Casper Q., et al.
Publicado: (2011)

Sclerosing Cholangitis in Behçet's Disease
por: Ben Slama Trabelsi, Aida, et al.
Publicado: (2013)

An Overview on Primary Sclerosing Cholangitis
por: Vlăduţ, Cătălina, et al.
Publicado: (2020)

Highly Increased Levels of Inter-α-inhibitor Heavy Chain 4 (ITIH4) in Autoimmune Cholestatic Liver Diseases
por: Laursen, Tea Lund, et al.
Publicado: (2022)

Long-Term Follow-Up into Adulthood of Pediatric-Onset Primary Sclerosing Cholangitis and Autoimmune Sclerosing Cholangitis
por: Hercun, Julian, et al.
Publicado: (2022)

Circulating cell-free messenger RNA secretome characterization of primary sclerosing cholangitis
por: Chalasani, Naga, et al.
Publicado: (2023)

Gut and Liver B Cells of Common Clonal Origin in Primary Sclerosing Cholangitis–Inflammatory Bowel Disease
por: Chung, Brian K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_21kk173num6vm769j5qi0sfl9b